Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sight Sciences, Inc. Director's Dealing 2025

Nov 27, 2025

33763_dirs_2025-11-26_8fe8a915-acba-4afe-b68a-3f59cde4c197.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sight Sciences, Inc. (SGHT)
CIK: 0001531177
Period of Report: 2025-11-25

Reporting Person: HAYDEN JEREMY B. (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-11-25 Common Stock M 37560 $1.96 Acquired 294150 Direct
2025-11-25 Common Stock M 7290 $1.96 Acquired 301440 Direct
2025-11-25 Common Stock S 44850 $8.08 Disposed 256590 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-11-25 Stock Option (Right to Buy) $1.96 M 37560 Disposed 2030-05-10 Common Stock (37560) Direct
2025-11-25 Stock Option (Right to Buy) $1.96 M 7290 Disposed 2030-07-28 Common Stock (7290) Direct

Footnotes

F1: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in connection with, and pursuant to, the terms of a marital separation agreement previously entered into between the Reporting Person and his former spouse. The Reporting Person's spouse will receive all proceeds from the shares sold in the transactions.

F2: Reflects the exercise of stock options awarded to the Reporting Person under the Issuer's equity incentive plan.

F3: Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $8.00 to $8.22, inclusive. The Reporting Person undertakes to provide to the Issuer,
any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The options are fully vested and exercisable.